Operating Lease, Right-of-Use Asset of TANDEM DIABETES CARE INC from 31 Mar 2019 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
TANDEM DIABETES CARE INC quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Mar 2019 to 31 Dec 2025.
  • TANDEM DIABETES CARE INC Operating Lease, Right-of-Use Asset for the quarter ending 31 Dec 2025 was $96,172,000, a 13% increase year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

TANDEM DIABETES CARE INC Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $96,172,000 +$10,866,000 +13% 31 Dec 2025 10-K 19 Feb 2026 2025 FY
Q3 2025 $98,364,000 +$10,971,000 +13% 30 Sep 2025 10-Q 06 Nov 2025 2025 Q3
Q2 2025 $98,436,000 +$10,193,000 +12% 30 Jun 2025 10-Q 06 Aug 2025 2025 Q2
Q1 2025 $101,017,000 +$12,731,000 +14% 31 Mar 2025 10-Q 30 Apr 2025 2025 Q1
Q4 2024 $85,306,000 -$2,485,000 -2.8% 31 Dec 2024 10-K 19 Feb 2026 2025 FY
Q3 2024 $87,393,000 -$2,041,000 -2.3% 30 Sep 2024 10-Q 06 Nov 2024 2024 Q3
Q2 2024 $88,243,000 -$2,811,000 -3.1% 30 Jun 2024 10-Q 01 Aug 2024 2024 Q2
Q1 2024 $88,286,000 -$16,457,000 -16% 31 Mar 2024 10-Q 02 May 2024 2024 Q1
Q4 2023 $87,791,000 -$22,835,000 -21% 31 Dec 2023 10-K 26 Feb 2025 2024 FY
Q3 2023 $89,434,000 -$27,040,000 -23% 30 Sep 2023 10-Q 01 Nov 2023 2023 Q3
Q2 2023 $91,054,000 -$35,618,000 -28% 30 Jun 2023 10-Q 03 Aug 2023 2023 Q2
Q1 2023 $104,743,000 -$26,315,000 -20% 31 Mar 2023 10-Q 03 May 2023 2023 Q1
Q4 2022 $110,626,000 +$83,123,000 +302% 31 Dec 2022 10-K 21 Feb 2024 2023 FY
Q3 2022 $116,474,000 +$86,791,000 +292% 30 Sep 2022 10-Q 02 Nov 2022 2022 Q3
Q2 2022 $126,672,000 +$95,173,000 +302% 30 Jun 2022 10-Q 03 Aug 2022 2022 Q2
Q1 2022 $131,058,000 +$97,785,000 +294% 31 Mar 2022 10-Q 04 May 2022 2022 Q1
Q4 2021 $27,503,000 +$7,730,000 +39% 31 Dec 2021 10-K 22 Feb 2023 2022 FY
Q3 2021 $29,683,000 +$8,358,000 +39% 30 Sep 2021 10-Q 03 Nov 2021 2021 Q3
Q2 2021 $31,499,000 +$9,946,000 +46% 30 Jun 2021 10-Q 04 Aug 2021 2021 Q2
Q1 2021 $33,273,000 +$10,259,000 +45% 31 Mar 2021 10-Q 05 May 2021 2021 Q1
Q4 2020 $19,773,000 +$4,212,000 +27% 31 Dec 2020 10-K 22 Feb 2022 2021 FY
Q3 2020 $21,325,000 +$4,748,000 +29% 30 Sep 2020 10-Q 05 Nov 2020 2020 Q3
Q2 2020 $21,553,000 +$3,888,000 +22% 30 Jun 2020 10-Q 30 Jul 2020 2020 Q2
Q1 2020 $23,014,000 +$12,927,000 +128% 31 Mar 2020 10-Q 30 Apr 2020 2019 Q1
Q4 2019 $15,561,000 31 Dec 2019 10-K 24 Feb 2021 2020 FY
Q3 2019 $16,577,000 30 Sep 2019 10-Q 04 Nov 2019 2019 Q3
Q2 2019 $17,665,000 30 Jun 2019 10-Q 01 Aug 2019 2019 Q2
Q1 2019 $10,087,000 31 Mar 2019 10-Q 30 Apr 2019 2019 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.